Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP
Medline is initiating a correction for specific convenience kits to remove Huons Bupivacaine Hydrochloride in Dextrose Injection components that were subject to a prior recall.
This affects Medline, healthcare facilities utilizing these specific convenience kits, and procurement departments responsible for managing surgical or anesthetic kit inventory.
This action highlights the regulatory risks associated with convenience kits where a recall of a single component necessitates an intervention for the entire finished package. It suggests that kit assemblers must maintain robust tracking systems to effectively execute field corrections when component-level safety issues arise.
QA and supply chain teams should immediately identify and sequester affected convenience kits to facilitate the removal of the recalled Huons Bupivacaine components as instructed by the manufacturer.
Medline is correcting affected convenience kits by removing recalled Bupivacaine Hydrochloride in Dextrose Injection components.
Open in openFDA / FDA.gov